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Abstract: Emerging and re-emerging infectious diseases and zoonoses indicate the importance of
the One Health (OH) approach for early warning. At present, even when surveillance data are
available, they are infrequently timeously shared between the health sectors. In the context of the
MediLabSecure (MLS) Project, we investigated the collection of a set of surveillance indicators able to
provide data for the implementation of integrated early warning systems in the 22 MLS countries
of the Mediterranean, Black Sea and Sahel regions. We used an online questionnaire (covering
vector, human, and animal sectors), focusing on seven relevant arboviruses, that was submitted to
110 officially appointed experts. Results showed that West Nile virus was perceived as the most
relevant zoonotic pathogen, while Dengue virus was the most relevant non-zoonotic pathogen in
the study area. Data collection of early warning indicators is in place at a different level for all the
investigated pathogens and in almost all the MLS Countries. Further assessments on the reliability
of the collection in place and on the feasibility of piloting an integrated early warning system for
arbovirus could verify if integrated early warning really represents the Achilles’ heel of OH.
Keywords: arbovirus; early warning; integrated surveillance; One Health
1. Introduction
The One Health (OH) concept is gathering greater attention over the last decades due to the
(re)emergence of human pathogens from animal reservoirs and the outcomes of studies on the impact
of environmental and climate changes on the transmission of several infectious diseases [1–4]. OH is
defined as a collaborative, multi-sectoral, and trans-disciplinary approach to optimizing health of
people, animals, and the shared environment [5]. At the global level, the World Organization for Animal
Health (OIE), the World Health Organization (WHO), and the Food and Agriculture Organization of
the United Nations (FAO) officially endorsed OH collaborations through a tripartite agreement and a
guide addressing zoonotic diseases [6,7].
The OH approach is promising in terms of surveillance and control of vector-borne diseases (VBDs)
because it makes use of trans-disciplinary cooperation at the human–animal–ecosystem interfaces [8,9].
Among VBDs, arboviruses have complex life cycles involving both human and animal hosts and, being
transmitted by arthropod vectors, are closely linked to environmental and climatic conditions [10].
Therefore, surveillance of VBD is one of the best examples of diseases benefiting from the establishment
of integrated systems in accordance with the OH concept [11–14].
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With limitations, integrated surveillance (“One Health surveillance describes the systematic
collection, validation, analysis, interpretation of data and dissemination of information collected
on humans, animals and the environment to inform decisions for more effective, evidence- and
system-based health interventions” [9]) systems for arbovirus infections have been implemented
in a number of countries [8,15,16]. It appears, however, that in the majority of the countries, even
when the different sectors involved (i.e., human, animal, entomological, and environmental) collect
surveillance data, rarely is this information shared in a timely manner between sectors to prevent
outbreaks. An early-warning capacity is therefore weak or lacking, and needs to be reinforced [15,17].
In fact, the identification of early warning indicators in association with rapid implementation of
prevention and control measures could reduce the severity of arbovirus epidemics [18,19]. Ad hoc
indicators can also highlight the vulnerability of countries or specific zones to the introduction and
spread of arbovirus infections, thus providing precious information to prevent the occurrence of
outbreaks and epidemics [20,21].
To tackle this, a number of studies have already been performed to predict the risk of VBDs
transmission using climate data [22–25], sectorial information from animals [26,27], from humans [28–30],
and from vectors [31–33].
This subject is crucial in the networking project named MediLabSecure (MLS), which involves
22 non-EU countries of the Mediterranean, Black Sea, and Sahel regions [34]. The network is focused
on strengthening integrated surveillance of arbovirus infections, given that the use of early warning
data is still considered “pioneeristic” in the MLS region [8].
To this aim, we identified a set of surveillance indicators that could assist in increasing regional
early-warning capacity and verified, through a survey, their collection at the national level.
2. Materials and Methods
The study focused on emerging and re-emerging arboviruses (Crimean-Congo haemorrhagic fever
virus–CCHFV, Chikungunya virus—CHIKV, Dengue virus—DENV, Rift Valley fever virus—RVFV,
West Nile virus—WNV, Yellow fever virus—YFV, and Zika virus—ZIKV) representing possible
priorities for the various geographical areas included in MLS network. Moreover, general interest to
these pathogens was confirmed in late 2018 during a OH scientific conference held in Rome [35] and
a OH workshop organized in Teramo [36] with representatives (i.e., public health and veterinarian
officers working at country level who were officially appointed to represent their institutions in the
MLS network) of the countries involved in the network. They highlighted, among gaps and needs,
that some of the surveillance systems currently in place were not adequate, and scarcity of integration
between the involved systems persists.
From January 2019, using scientific references [10,20,21,26,37] and grey literature [38–40], we
identified possible indicators for highlighting vulnerabilities of MLS countries to the selected arboviral
diseases. A set (from four to six) of potential indicators were identified for each pathogen and sector
involved in arbovirus surveillance (entomology, human health, and, in the case of zoonotic pathogens,
animal health). MLS experts in entomology, human and animal virology, public health, and animal
health reviewed the selected indicators and we finalized the list.
In order to gather local information about the utilization of potential indicators in the countries
of the MLS network, we developed an online questionnaire using Google Form©. A draft form of
the questionnaire was piloted by a small group of external experts who assessed appropriateness of
wording, comprehensibility, clarity of the instructions, and time needed to complete the questionnaire.
We implemented the questionnaire in three versions (for vector, human, and animal sectors),
harbouring common features and sector-specific questions for each pathogen (see Supplementary
Materials). At the beginning of each section, we asked about the relevance of the pathogen for the
specific country; a definition of “relevance” was given as follows: “an endemic or epidemic pathogen in
the country, or an emerging pathogen not yet identified in the country.” If the pathogen was considered
relevant, questions on the collection of indicators specifically for that pathogen were then proposed.
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The questionnaire version for animal virologists and veterinary public health workers included only
zoonotic pathogens.
In May 2019, the three versions of the online questionnaire were submitted to 110 officially
appointed contact points of the 22 countries of the MLS network. The version focusing on vectors
was sent to entomologists, that on human indicators to human virologists and human public health
professionals, and that on animal indicators to animal virologists and veterinary services professionals.
Several reminders were sent out for completion from June to July, and answers were collected until
September 2019. Information collected through the survey administration app was then compiled and
analyzed using MS Excel 2016©.
3. Results
3.1. Selected Indicators
The indicators selected among those identified from the literature are reported in Table 1.
Table 1. Selected potential indicators for early warning.
Sector Type of Indicator Specific Indicators
Vector Pathogen-specific
Vector presence
Vector abundance/density
Vector seasonality
Vector infection rate
Human
General
Population density
Population age distribution
Pathogen-specific
Disease frequency or occurrence—new notified cases/outbreaks
(according to National case definition) per year
Disease frequency or occurrence—number confirmed laboratory
cases (according to National case definition) per year
Disease frequency or occurrence—persons with detected
antibodies (sero-prevalence)
Animal
General
Animal population density 1
Animal movements and trade—pastoralism and transhumance
Animal movements and trade—import and export
Animal movements and trade—wildlife migrations
Pathogen-specific 2
Animal disease occurrence
Animal disease seroprevalence
1 We investigated the collection of the same indicator in different animal species/group (cattle, goats, sheep, equids,
camels, wild ruminants, non-ruminant wild animals, and wild birds). 2 Per each pathogen, we investigated the
collection of the same indicator in the susceptible animal species: for Crimean-Congo haemorrhagic fever virus
(CCHFV), cattle, goats, sheep, camels, wild ruminants, non-ruminant wild animals, and wild birds; for Rift Valley
fever virus (RVFV), cattle, goats, sheep, camels, wild ruminants, and non-ruminant wild animals; lastly, for West
Nile virus (WNV), equids and wild birds.
Vectors (mosquitoes for six out of seven selected pathogens, and ticks for CCHFV) were investigated
in terms of presence, abundance/density, seasonality, and infection rate.
For humans, two general indicators (population density and population age distribution), and three
pathogen-specific indicators regarding disease frequency or occurrence were considered.
The animal-related version of the questionnaire investigated only three zoonotic pathogens:
CCHFV, RVFV, and WNV. Questions regarding the collection of two general indicators were asked
(animal population density, and animal movements and trade). Furthermore, the pathogen-specific
indicators were animal disease occurrence and animal disease seroprevalence.
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3.2. Questionnaire Responsiveness
Overall, 21 of the 22 MLS network countries responded with at least one completed questionnaire.
Countries’ responsiveness was higher in the entomology sector (20/22), followed by the animal (30/44)
and human sectors (28/44). In some of the MLS countries, the public health sector is divided on a
regional basis, therefore in two cases more than one questionnaire was completed for the same sector.
As a result, a total number of 81 questionnaires were collected and analyzed: 20 from entomologists,
31 from animal virologists and the official veterinary sector, and 30 from human virologists and
the public health sector. Zoonotic pathogens (CCHFV, RVFV, and WNV) were investigated in 81
questionnaires, while 50 questionnaires concerned non-zoonotic pathogens (CHIKV, DENV, YFV,
and ZIKV).
3.3. Pathogens Relevance
3.3.1. National Level
From the questionnaire responses, WNV was perceived as the most relevant zoonotic pathogen
in the study area, followed by CCHFV and RVFV. Specifically, WNV was relevant for 73% (59/81) of
respondents, CCHFV for 63% (51/81), and RVFV for 49% (40/81) (Table 2). Among the non-zoonotic
pathogens, DENV was perceived as the most important in the study area as it was considered relevant
for 62% (31/50) of the respondents (Table 3). Less relevant non-zoonotic pathogens were CHIKV at 46%
(23/50), ZIKV at 40% (20/50), and YFV at 38% (19/50). Percentages of relevance per individual pathogen
in the overall study area and within the different sectors are reported below in Tables 2 and 3.
Table 2. Zoonotic pathogens perceived relevance in the study area and by sectors.
Pathogens Overall Relevancein the Study Area
Sector Relevance
(Vector)
Sector Relevance
(Human)
Sector Relevance
(Animal)
West Nile virus 59/81 (73%) 18/20 (90%) 22/30 (73%) 18/31 (61%)
Crimean-Congo
Haemorrhagic Fever virus 51/81 (63%) 14/20 (70%) 20/30 (67%) 17/31 (55%)
Rift Valley fever virus 40/81 (49%) 11/20 (55%) 13/30 (43%) 16/31 (52%)
Table 3. Non-zoonotic pathogens perceived relevance in the study area and by sectors.
Pathogens Overall Relevance inthe Study Area
Sector Relevance
(Vector)
Sector Relevance
(Human)
Dengue virus 31/50 (62%) 13/20 (65%) 18/30 (60%)
Chikungunya virus 23/50 (46%) 11/20 (55%) 12/30 (40%)
Zika virus 20/53 (40%) 9/20 (45%) 11/30 (37%)
Yellow fever virus 19/53 (38%) 8/20 (40%) 11/30 (37%)
3.3.2. Regional Level
In line with the aim of implementing early detection strategies in the MLS network area, the regional
relevance of the selected pathogens was analyzed (Table 4). To accomplish this, the 22 countries
of the study area were grouped in five regions, namely Balkans (Albania, Bosnia & Herzegovina,
Kosovo, Montenegro, Republic of North Macedonia, and Serbia), Black Sea (Armenia, Georgia,
and Turkey), Middle East (Jordan, Lebanon, and Palestine), North Africa (Algeria, Egypt, Libya,
Morocco, and Tunisia), and Sahel (Burkina Faso, Mali, Mauritania, Niger, and Senegal).
Within the regionally grouped data, WNV was the most relevant pathogen for the respondents
from Balkans and North Africa; for Black Sea region CCHFV was the most important; in Middle East
region DENV was considered relevant, whereas all respondents from the Sahel region considered
RVFV as the most important.
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Table 4. Regional relevance of the investigated pathogens.
Region CHIKV CCHFV DENV YFV RVFV WNV ZIKV
Balkans 8/16 (50%) 22/27 (81%) 9/16 (56%) 5/16 (31%) 10/27 (37%) 26/27 (96%) 6/16 (38%)
Black Sea 1/7 (14%) 9/11 (82%) 1/7 (14%) 1/7 (14%) 1/11 (9%) 7/11 (64%) 1/7 (14%)
Middle East 5/6 (83%) 4/11 (36%) 6/6 (100%) 3/6 (50%) 5/11 (45%) 7/11 (64%) 3/6 (50%)
North Africa 5/13 (38%) 6/19 (32%) 8/13 (62%) 6/13 (46%) 11/19 (58%) 16/19 (84%) 6/13 (46%)
Sahel 4/8 (50%) 10/13 (77%) 7/8 (88%) 4/8 (50%) 13/13 (100%) 3/13 (23%) 4/8 (50%)
3.4. Surveillance Systems
To investigate the surveillance systems in place in each sector for the different pathogens, questions
about which indicators are routinely collected were asked. Tables 5–7 show the level of collection
of each indicator for the four most relevant pathogens (WNV, CCHFV, DENV, and RVFV) in the
study area.
Table 5. Collection of selected indicators for vectors for WNV, CCHFV, Dengue virus (DENV), and RVFV.
Indicators Collected-Vector WNV CCHFV DENV RVFV
Vector presence 12/18 (67%) 7/14 (50%) 11/13 (85%) 5/11 (45%)
Vector abundance/density 8/18 (44%) 2/14 (14%) 9/13 (69%) 4/11 (36%)
Vector seasonality 8/18 (44%) 4/14 (29%) 10/13 (77%) 3/11 (27%)
Vector infection rate 6/18 (33%) 3/14 (21%) 1/13 (8%) 1/11 (9%)
Table 6. Collection of selected indicators for humans for WNV, CCHFV, DENV, and RVFV.
Indicators Collected-Human General Indicators WNV CCHFV DENV RVFV
Population density 27/30 (90%)
Population age distribution 27/30 (90%)
Disease frequency or occurrence—new
notified cases/outbreaks (according to
National case definition) per year
20/22
(91%)
18/20
(90%)
14/18
(78%)
10/13
(77%)
Disease frequency or
occurrence—number of confirmed
laboratory cases (according to National
case definition) per year
19/22
(86%)
17/20
(85%)
13/18
(72%)
10/13
(77%)
Disease frequency or
occurrence—persons with specific
antibodies (seroprevalence)
13/22
(59%)
11/20
(55%)
9/18
(50%)
7/13
(54%)
Table 7. Collection of selected indicators for animals for WNV, CCHFV, and RVFV.
Indicators Collected-Animals General Indicators WNV CCHFV RVFV
Animal population density 1 31/31 (100%)
Animal movements and trade—pastoralism
and transhumance 20/31 (65%)
Animal movements and trade—import and export 30/31 (97%)
Animal movements and trade—wildlife migrations 5/31 (16%)
Animal disease occurrence 2 14/19 (74%) 8/17 (47%) 11/16 (69%)
Animal disease seroprevalence 2 12/19 (63%) 8/17 (47%) 10/16 (63%)
1 Animal population information collection involves 100% of the cases for cattle, goats, and sheep, and to a lesser
extent for equids and camels, while rarely for wild species. 2 These indicators correspond to equids for WNV and
cattle, goats, and sheep for CCHFV and RVFV.
The most frequently collected indicator in the entomology sector is “vector presence,” regardless
of the involved pathogen, while data on “vector infection rate” are rarely gathered (Table 5).
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The results from the human sector questionnaires show that population density and population
age distribution data are collected in almost all cases (Table 6). To evaluate disease frequency or
occurrence, the most frequently collected data are new cases (new notified cases or outbreaks, according
to the national case definition, per year) and laboratory cases (number of confirmed laboratory cases,
according to national case definition, per year).
Data on animal population are collected in 100% of the cases for cattle, goats, and sheep, and to a
lesser extent for equids and camels; these data are rarely collected for wild species. Data on animal
movements and trade are frequently collected in terms of import and export, and quite often for
pastoralism and transhumance practices. Wild animal information (wildlife migrations) is again
gathered very rarely. Data regarding disease occurrence and disease seroprevalence in animals are
collected to a different extent depending on the pathogen considered (Table 7).
4. Discussion
As stated by Leta et al. [41], arboviral diseases are indeed a global public health threat considering
that 215 countries/territories are potentially suitable for the most important arboviral disease vectors
(A. aegypti and A. albopictus) and more than half of these areas are reporting cases of Zika, Dengue
fever, Chikungunya, Yellow fever, and/or Rift Valley fever.
The pathogens’ relevance perceived by the respondents of our survey is in accordance with their
diffusion in the region. WNV is the most widely distributed arbovirus on the planet [42]; RVFV is
relevant mainly for African countries, even if it is suggested that other regions of the MLS network are
suitable for potentially competent RVFV vectors and may be considered at risk of introduction through
uncontrolled movements of infected animals from infected neighboring countries [43]. CCHFV, clearly
acknowledged in the Black Sea and Balkans regions as a priority, is not considered relevant by the
respondents from both the Middle East and North Africa, despite its main vector being present in both
regions, and virological and serological evidences were highlighted in some of those countries [44].
The results for YFV suggest that it is perceived as the least important pathogen, perhaps in light of the
widespread and effective vaccination programs in progress for 50 years [45]. Overall, the relevance
ranking of pathogens is the same within the three sectors, demonstrating that shared priorities exist
and that there is strong potential for integrated strategies.
According to the information gathered by our survey, the collection of indicators suitable for
early warning is in place with a range of different situations in the MLS network countries. At this
stage, it would be possible, albeit challenging, to identify opportunities for targeting disease threats
upstream (prevention at the source, or via early detection and effective response) in order to support
the reduction of occurrence and impact of arboviruses transmission [46].
From the questionnaire results, vector presence predictably resulted as the most collected
vector indicator. On the contrary, vector infection rate was the most difficult to gather in case of
mosquitos-transmitted pathogens, while for CCHFV (transmitted by ticks) the least collected indicator
is vector abundance/density. Therefore, vector species-specific differences should be taken into
consideration when interpreting these results. This said, a limitation of the present study is the use
of the same indicators regardless of the vector species involved (for example, does data on “vector
abundance/density” have the same significance for ticks rather than for mosquitoes?). Moreover,
different people and/or different laboratories of the same institution may focus on specific vector
species (i.e., mosquitoes or ticks); as a result, addressing our questionnaire to only one of them may
have limited the collection of information or biased the results. However, in order to mitigate this
risk, we strongly recommended our contact points to share the questionnaire with relevant colleagues
when appropriate. Information on vector seasonality is instead less available, although by analyzing
the collection of this indicator by country and by pathogen, coherent explanations might be found
(e.g., endemicity of the pathogen in the concerned country with the assumption that the vector is
abundant throughout the year). Nevertheless, lack of awareness on the importance of some indicators
for the monitoring of certain pathogens could also explain their unsuccessful collection.
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Data on disease frequency or occurrence in humans (both either suspected cases or lab confirmed)
is collected by the majority of the countries involved. On the other hand, less effort is dedicated to
seroprevalence studies, despite their potential importance in areas where the disease has been not
reported yet.
Interestingly, information on animal population density is collected in all the involved countries
for some domestic species, supplying national authorities with important data for animal disease
surveillance. However, information regarding wildlife is rarely gathered: surveillance programs
in wildlife are needed and desirable, not only in order to investigate the health status of wildlife
populations, but also to investigate on potential reservoir of infection and, therefore, to prevent the
spillover in animals and humans [47].
A final section in all the questionnaires allowed for the collection of information on indicators
relevant to climate and environment (temperature, precipitations, meteorological stations, vegetation,
land use, land cover, and soil type). The preliminary analysis of this information shows that this
collection should be strengthened, especially in light of the increasing environmental and climate
impact on the diffusion of arboviruses.
Collecting data through an online questionnaire proved to be the most convenient and effective
solution to quickly gather information from the MLS region. However, this method has some
disadvantages: it was not possible to verify the quality (completeness, uniformity, etc.) of data collection
in place, nor to investigate individual special cases discovered with the study.
Having assessed that each of the sectors involved in the surveillance was collecting indicators for
the most relevant arboviral infections in the MLS region, the next step is to verify if a specific selection
of appropriate indicators amongst those presently collected can provide the ability to predict or allow
for early warning, especially in terms of a One Health perspective (“integrated early warning”).
The piloting of such a type of integrated approach could help to understand if integrated early
warning represents the Achilles’ heel of OH, until more effort will be put into setting up all the
requirements needed to operationalize such a system. Among others, the need to increase the
performance of the system is crucial in terms of sensibility and specificity through the integration of
data from different sources and Institutions. This is only possible with the presence of shared or closely
connected information systems, procedures, and indicators.
5. Conclusions
A certain grade of collection of surveillance data (indicators) is already in place in the MLS region.
Their collection should be strengthened and the gaps on critical indicators addressed (i.e., vector
infection rate and wildlife information).
It appears now worthwhile proceeding with further assessments which can help clarify the
reliability of the indicators collected and the feasibility of the implementation of an integrated early
warning system for arboviral infections. Since some relevant indicators are already being collected,
this would not demand for extra resources but, on the contrary, its operationalization could lead to
savings. Deep studies in promising countries could help to address the problem and would represent
the chance to pilot integrated early warning systems using data already being collected and to promote
the collection of critical data not yet gathered.
As stated by Berthe et al.: “One Health is a sound management approach, fully aligned with the
definition of ‘health,’ and good practice for its predicament on the use of increasingly scarce resources,
therefore improving efficiency and efficacy” [46]. Let us see if this is also the case of early warning for
arboviral infections.
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Velo, E.; et al. Towards harmonisation of entomological surveillance in the Mediterranean area. PLoS Negl.
Trop. Dis. 2019, 13, e0007314. [CrossRef]
15. Riccardo, F.; Monaco, F.; Bella, A.; Savini, G.; Russo, F.; Cagarelli, R.; Dottori, M.; Rizzo, C.; Venturi, G.;
Di Luca, M.; et al. An early start of West Nile virus seasonal transmission: The added value of One
Heath surveillance in detecting early circulation and triggering timely response in Italy, June to July 2018.
Euro Surveill. 2018, 23, 1800427. [CrossRef] [PubMed]
16. Vrbova, L.; Stephen, C.; Kasman, N.; Boehnke, R.; Doyle-Waters, M.; Chablitt-Clark, A.; Gibson, B.;
FitzGerald, M.; Patrick, D.M. Systematic Review of Surveillance Systems for Emerging Zoonoses. Transbound.
Emerg. Dis. 2010, 57, 154–161. [CrossRef] [PubMed]
17. Dente, M.G.; Riccardo, F.; Van Bortel, W.; Marrama, L.; Mollet, T.; Derrough, T.; Sudre, B.; Calistri, P.;
Declich, S. Enhancing preparedness for arbovirus infections with a One Health approach: The development
and implementation of Multisectoral Risk Assessment Exercises. BioMed Res.. under review.
18. Consultative Group for RVF Decision Support. Decision-support tool for prevention and control of Rift
Valley fever epizootics in the Greater Horn of Africa. Am. J. Trop. Med. Hyg. 2010, 83, 75–85. [CrossRef]
19. Nguku, P.M.; Sharif, S.K.; Mutonga, D.; Amwayi, S.; Omolo, J.; Mohammed, O.; Farnon, E.C.; Gould, L.H.;
Lederman, E.; Rao, C.; et al. An investigation of a major outbreak of rift valley fever in Kenya: 2006–2007.
Am. J. Trop. Med. Hyg. 2010, 83, 5–13. [CrossRef]
20. Fullerton, L.M.; Dickin, S.K.; Schuster-Wallace, C.J. Mapping Global Vulnerability to Dengue Using the Water
Associated Disease Index; United Nations University: Kuala Lumpur, Malaysia, 2014. [CrossRef]
21. Ben Hassine, T.; Conte, A.; Calistri, P.; Candeloro, L.; Ippoliti, C.; De Massis, F.; Danzetta, M.L.; Bejaoui, M.;
Hammami, S. Identification of Suitable Areas for West Nile Virus Circulation in Tunisia. Transbound. Emerg.
Dis. 2017, 64, 449–458. [CrossRef]
22. Ezanno, P.; Aubry-Kientz, M.; Arnoux, S.; Cailly, P.; L’Ambert, G.; Toty, C.; Balenghien, T.; Tran, A. A generic
weather-driven model to predict mosquito population dynamics applied to species of Anopheles, Culex and
Aedes genera of southern France. Prev. Vet. Med. 2015, 120, 39–50. [CrossRef]
23. Lowe, R.; Barcellos, C.; Coelho, C.A.S.; Bailey, T.C.; Coelho, G.E.; Graham, R.; Jupp, T.; Ramalho, W.M.;
Carvalho, M.S.; Stephenson, D.B.; et al. Dengue outlook for the World Cup in Brazil: An early warning model
framework driven by real-time seasonal climate forecasts. Lancet Infect. Dis. 2014, 14, 619–626. [CrossRef]
24. Lowe, R.; Stewart-Ibarra, A.M.; Petrova, D.; García-Díez, M.; Borbor-Cordova, M.J.; Mejía, R.; Regato, M.;
Rodó, X. Climate services for health: Predicting the evolution of the 2016 dengue season in Machala, Ecuador.
Lancet Planet. Health 2017, 14, e142–e151. [CrossRef]
25. Anyamba, A.; Chretien, J.P.; Small, J.; Tucker, C.J.; Formenty, P.B.; Richardson, J.H.; Britch, S.C.; Schnabel, D.C.;
Erickson, R.L.; Linthicum, K.J. Prediction of a Rift Valley fever outbreak. Proc. Natl. Acad. Sci. USA 2009, 106,
955–959. [CrossRef]
26. Munyua, P.M.; Murithi, R.M.; Ithondeka, P.; Hightower, A.; Thumbi, S.M.; Anyangu, S.A.; Kiplimo, J.; Bett, B.;
Vrieling, A.; Robert Breiman, F.; et al. Predictive factors and risk mapping for Rift Valley fever epidemics in
Kenya. PLoS ONE 2016, 11, e0144570. [CrossRef] [PubMed]
27. Munyua, P.; Murithi, R.M.; Wainwright, S.; Githinji, J.; Hightower, A.; Mutonga, D.; Macharia, J.;
Ithondeka, P.M.; Musaa, J.; Breiman, R.F.; et al. Rift Valley fever outbreak in livestock in Kenya, 2006–2007.
Am. J. Trop. Med. Hyg. 2010, 83, 58–64. [CrossRef] [PubMed]
28. Boaz, R.; Corberán-Vallet, A.; Lawson, A.; de Ferreira Lima, F.E., Jr.; Edel Donato, L.; Vieira Alves, R.;
Machado, G.; Freire de Carvalho, M.; Pompei, J.; Del Rio Vilas, V.J. Integration of animal health and
public health surveillance sources to exhaustively inform the risk of zoonosis: An application to visceral
leishmaniasis data in Brazil. Spat. Spatio-Temporal Epidemiol. 2019, 29, 177–185. [CrossRef] [PubMed]
29. Rotejanaprasert, C.; Lawson, A.; Rossow, H.; Sane, J.; Huitu, O.; Henttonen, H.; Del Rio Vilas, V.J. Towards
integrated surveillance of zoonoses: Spatiotemporal joint modeling of rodent population data and human
tularemia cases in Finland. BMC Med. Res. Methodol. 2018, 18, 72. [CrossRef] [PubMed]
30. Corberán-Vallet, A.; Lawson, A.B. Prospective analysis of infectious disease surveillance data using syndromic
information. Stat. Methods Med. Res. 2014, 23, 572–590. [CrossRef]
Microorganisms 2020, 8, 84 10 of 10
31. Kraemer, M.U.; Sinka, M.E.; Duda, K.A.; Mylne, A.Q.; Shearer, F.M.; Barker, C.M.; Moore, C.G.; Carvalho, R.G.;
Coelho, G.E.; Van Bortel, W.; et al. The global distribution of the arbovirus vectors Aedes aegypti and Ae.
albopictus. ELife 2015, 4, e08347. [CrossRef]
32. Kraemer, M.U.G.; Reiner, R.C.; Brady, O.J.; Messina, J.P.; Gilbert, M.; Pigott, D.M.; Yi, D.; Johnson, K.; Earl, L.;
Marczak, L.B.; et al. Past and future spread of the arbovirus vectors Aedes aegypti and Aedes albopictus.
Nat. Microbiol. 2019, 4, 854–863. [CrossRef]
33. Kjær, L.J.; Soleng, A.; Edgar, K.S.; Lindstedt, H.E.H.; Paulsen, K.M.; Andreassen, Å.K.; Korslund, L.;
Kjelland, V.; Slettan, A.; Stuen, S.; et al. Predicting and mapping human risk of exposure to ixodes ricinus
nymphs using climatic and environmental data, Denmark, Norway and Sweden, 2016. Euro Surveill. 2019,
24, 1800101. [CrossRef]
34. MediLabSecure—Homepage. Available online: https://www.medilabsecure.com/ (accessed on 16 October 2019).
35. MediLabSecure—One Health Conference. Available online: https://www.medilabsecure.com/public.aspx?
page=events_meetings_onehealthconference2018 (accessed on 1 December 2019).
36. MediLabSecure—One Health Workshop. Available online: https://www.medilabsecure.com/public.aspx?
page=workshop_ph_teramo (accessed on 1 December 2019).
37. European Centre for Disease Prevention and Control; European Food Safety Authority. The Importance of
Vector Abundance and Seasonality—Results from an Expert Consultation; ECDC and EFSA: Stockholm, Sweden;
Parma, Italy, 2018; pp. 1–43. [CrossRef]
38. Moreland, S.; Morris, L.; Smith, E. One Health Policy Model—User Guide and Technical Description; United
States Agency for International Development (USAID): Washington, DC, USA, 2018.
39. Lowe, R. Climate Services and Early Warning Systems for Infectious Disease Outbreaks. In Proceedings of
the THET Annual Conference, London, UK, 24 October 2017.
40. Centers for Disease Control and Prevention; United States Agency for International Development; Food and
Agriculture Organization. One Health Zoonotic Disease Prioritization for Multi-Sectoral Engagement in Burkina
Faso; Centers for Disease Control and Prevention: Atlanta, GA, USA, 2019.
41. Leta, S.; Beyene, T.J.; De Clercq, E.M.; Amenu, K.; Kraemer, M.U.G.; Revie, C.W. Global risk mapping for major
diseases transmitted by Aedes aegypti and Aedes albopictus. Int. J. Infect. Dis. 2018, 67, 25–35. [CrossRef]
42. Kramer, L.D.; Styer, L.M.; Ebel, G.D. A Global Perspective on the Epidemiology of West Nile Virus. Annu. Rev.
Entomol. 2008, 53, 61–81. [CrossRef]
43. EFSA Panel on Animal Health and Welfare (AHAW). Scientific Opinion on Rift Valley fever. EFSA J. 2013,
11, 3180. [CrossRef]
44. WHO Emergencies—Crimean-Congo Haemorrhagic Fever (CCHF). Available online: https://www.who.int/
emergencies/diseases/crimean-congo-haemorrhagic-fever/en/ (accessed on 28 October 2019).
45. Wilder-Smith, A. Yellow fever vaccination: Estimating coverage. Lancet Infect. Dis. 2017, 17, 1109–1111.
[CrossRef]
46. Berthe, F.C.J.; Bouley, T.; Karesh, W.B.; Le Gall, F.G.; Machalaba, C.C.; Plante, C.A.; Seifman, R.M. Operational
Framework for Strengthening Human, Animal and Environmental Public Health Systems at Their Interface; The World
Bank: Washington, DC, USA, 2018.
47. Morner, T.; Obendorf, D.L.; Artois, M.; Woodford, M.H. Surveillance and monitoring of wildlife diseases.
Rev. Sci. Tech. 2002, 21, 67–76. [CrossRef] [PubMed]
48. MediLabSecure—Participating Countries. Available online: https://www.medilabsecure.com/countries.html
(accessed on 18 October 2019).
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
